Corebridge Financial’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-66,015
Closed -$98.4K 2015
2025
Q1
$98.4K Sell
66,015
-979
-1% -$1.54K ﹤0.01% 2445
2024
Q4
$75K Sell
66,994
-689
-1% -$588 ﹤0.01% 2691
2024
Q3
$64.1K Sell
67,683
-418
-0.6% -$527 ﹤0.01% 2792
2024
Q2
$108K Buy
+68,101
New +$98.9K ﹤0.01% 2560

Other funds holding PGEN

Corebridge Financial's PGEN Position: Q2 2025 in Review

Corebridge Financial sold out of Precigen (PGEN) in Q2 2025, closing a stake of 66,015 shares — an estimated $98.4K sold.

Corebridge Financial first reported a position in PGEN in Q2 2024 and held it in 4 quarters. The position peaked at $108K in Q2 2024. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

  • Corebridge Financial reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 66,015 Precigen shares in Q2 2025, an estimated $98.4K.
  • Corebridge Financial first reported a position in Precigen in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Precigen position peaked at $108K in Q2 2024.
  • 147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.